| 1 |
35216667 | Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. | 2022 Apr 7 |
1 |
| 2 |
35318312 | Single-cell RNA-sequencing analysis reveals MYH9 promotes renal cell carcinoma development and sunitinib resistance via AKT signaling pathway. | 2022 Mar 22 |
3 |
| 3 |
33893075 | G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related Phosphoproteomic Signatures in Renal Cell Carcinoma. | 2021 May-Jun |
1 |
| 4 |
34765076 | Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial. | 2021 Oct |
1 |
| 5 |
30281919 | NT5E inhibition suppresses the growth of sunitinib-resistant cells and EMT course and AKT/GSK-3β signaling pathway in renal cell cancer. | 2019 Jan |
1 |
| 6 |
30821250 | Synergic effects of inhibition of glycolysis and multikinase receptor signalling on proliferation and migration of endothelial cells. | 2019 Mar |
1 |
| 7 |
29435010 | Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis. | 2018 Mar |
1 |
| 8 |
30369518 | Interleukin-6 induces drug resistance in renal cell carcinoma. | 2018 Dec 8 |
1 |
| 9 |
28327411 | Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages. | 2017 Jun 1 |
1 |
| 10 |
28898759 | Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer. | 2017 Nov |
1 |
| 11 |
28903416 | Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade. | 2017 Aug 15 |
1 |
| 12 |
27016208 | Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations. | 2016 Aug |
1 |
| 13 |
27538132 | [Sunitinib induces autophagy via suppressing Akt/mTOR pathway in renal cell carcinoma]. | 2016 Feb 18 |
3 |
| 14 |
29263493 | [Sunitinib induces autophagy via suppressing Akt/mTOR pathway in renal cell carcinoma]. | 2016 Aug 18 |
3 |
| 15 |
25637219 | AXL as a modulator of sunitinib response in glioblastoma cell lines. | 2015 Mar 1 |
3 |
| 16 |
25917740 | Enhanced Sensitivity to Sunitinib by Inhibition of Akt1 Expression in Human Castration-resistant Prostate Cancer PC3 Cells Both In Vitro and In Vivo. | 2015 May |
5 |
| 17 |
25993161 | Biology and clinical management challenges in meningioma. | 2015 |
1 |
| 18 |
26788996 | Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor. | 2015 |
1 |
| 19 |
24018642 | Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer. | 2014 Jan 1 |
1 |
| 20 |
24045439 | Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy. | 2014 Apr |
1 |
| 21 |
24974736 | Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis. | 2014 Aug |
1 |
| 22 |
25109654 | Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line. | 2014 Oct |
1 |
| 23 |
25130811 | [Effect of SU11248 on leukemia cell line K562 and its molecular mechanisms]. | 2014 Aug |
2 |
| 24 |
23812726 | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. | 2013 Dec |
1 |
| 25 |
23969186 | Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1. | 2013 Sep |
3 |
| 26 |
21445973 | Long-term exposure of gastrointestinal stromal tumor cells to sunitinib induces epigenetic silencing of the PTEN gene. | 2012 Feb 15 |
1 |
| 27 |
21445974 | Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway. | 2012 Feb 15 |
4 |
| 28 |
22338018 | New strategies for advanced neuroendocrine tumors in the era of targeted therapy. | 2012 Apr 1 |
1 |
| 29 |
22532600 | Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells. | 2012 Jul |
1 |
| 30 |
22733151 | Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma. | 2012 Oct |
2 |
| 31 |
23650573 | IGF-1 receptor is down-regulated by sunitinib induces MDM2-dependent ubiquitination. | 2012 |
1 |
| 32 |
21187670 | Effect of sunitinib combined with ionizing radiation on endothelial cells. | 2011 |
1 |
| 33 |
21344032 | Sunitinib malate synergistically potentiates anti-tumor effect of gemcitabine in human bladder cancer cells. | 2011 Jan |
2 |
| 34 |
21693010 | Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3. | 2011 Jun 21 |
1 |
| 35 |
20053726 | Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways. | 2010 Jan |
3 |
| 36 |
19467916 | FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML. | 2009 Jun |
1 |
| 37 |
18514780 | SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation. | 2008 Jul 1 |
1 |
| 38 |
16916320 | Effect of SU11248 on gastrointestinal stromal tumor-T1 cells: enhancement of growth inhibition via inhibition of 3-kinase/Akt/mammalian target of rapamycin signaling. | 2006 Sep |
3 |